B I O P E O P L E
Zydus appoints Punit Patel as President & CEO to lead its business operations in North America
coupled with his people leadership and results-driven style , unlocks value by enabling long-term strategy to be translated into actionable plans .
Dr Sharvil Patel , Managing Director , Zydus Lifesciences said , “ As a seasoned and successful business leader , Punit brings rich and varied experience in healthcare and pharmaceuticals to lead Zydus into the future .”
OPPI appoints Anil Matai as Director-General
Zydus Lifesciences Limited has announced the appointment of Punit Patel as President and Chief Executive Officer , Americas . Punit will be responsible for the business operations of all Zydus entities in North America which include generics , injectables and specialty business , rare and orphan disease portfolio and also future forays into novel therapeutics . He will be based out of the group ’ s office in Pennington , New Jersey , U . S .
A licensed pharmacist who earned his Doctorate of Pharmacy from Massachusetts College of Pharmacy and Allied Health Sciences , Punit Patel has more than 20 years of experience in the generics and branded pharmaceutical marketplace . His deep understanding of the complex generic pharmaceutical market ( specialty , 505b2 , injectables & biosimilars ),
The Organisation of Pharmaceutical Producers of India ( OPPI ), which represents global research-based pharmaceutical companies , has appointed Anil Matai as its Director General . Anil Matai , a seasoned general management professional , has extensive experience in the Life Sciences space having worked across MNCs including spearheading operations across Novartis India Ltd , GSK India , and Global Pharma , Dubai .
After superannuating as Managing
76
BioVoiceNews | November / December 2023